XNCR Q1 2023 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M-77.8% YoY

Gross Profit

-$47M-245.7% margin

Operating Income

-$61M-320.3% margin

Net Income

-$61M-320.4% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

-12.3%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$42M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$803M

Total Liabilities

$120M

Stockholders' Equity

$684M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$85M	-77.8%
Gross Profit	-$47M	$38M	-223.5%
Operating Income	-$61M	$26M	-329.5%
Net Income	-$61M	$24M	-357.5%

Revenue Segments

Royalty

$14M73%

Milestone

$5M26%

Research collaboration

$200,0001%